Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("YIOTAKIS, Athanasios")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 16 of 16

  • Page / 1
Export

Selection :

  • and

Specific targeting of metzincin family members with small-molecule inhibitors: Progress toward a multifarious challengeGEORGIADIS, Dimitris; YIOTAKIS, Athanasios.Bioorganic & medicinal chemistry. 2008, Vol 16, Num 19, pp 8781-8794, issn 0968-0896, 14 p.Article

Synthesis of the Phosphinic Analogue of Thyrotropin Releasing HormoneMATZIARI, Magdalini; BAUER, Karl; DIVE, Vincent et al.Journal of organic chemistry. 2008, Vol 73, Num 21, pp 8591-8593, issn 0022-3263, 3 p.Article

Chemoselective protection of solid-phase compatible Fmoc-phosphinic building blocksNASOPOULOU, Magdalini; MATZIARI, Magdalini; DIVE, Vincent et al.Journal of organic chemistry. 2006, Vol 71, Num 25, pp 9525-9527, issn 0022-3263, 3 p.Article

A versatile annulation protocol toward novel constrained phosphinic peptidomimeticsNASOPOULOU, Magdalini; GEORGIADIS, Dimitris; MATZIARI, Magdalini et al.Journal of organic chemistry. 2007, Vol 72, Num 19, pp 7222-7228, issn 0022-3263, 7 p.Article

Evaluation of P1'-Diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11MATZIARI, Magdalini; BEAU, Fabrice; CUNIASSE, Philippe et al.Journal of medicinal chemistry (Print). 2004, Vol 47, Num 2, pp 325-336, issn 0022-2623, 12 p.Article

A synthetic method for diversification of the P1' substituent in phosphinic dipeptides as a tool for exploration of the specificity of the S1' binding pockets of leucine aminopeptidasesVASSILIOU, Stamatia; XEILARI, Metaxia; YIOTAKIS, Athanasios et al.Bioorganic & medicinal chemistry. 2007, Vol 15, Num 9, pp 3187-3200, issn 0968-0896, 14 p.Article

Development of Potent and Selective Phosphinic Peptide Inhibitors of Angiotensin-Converting Enzyme 2MORES, Andreas; MATZIARI, Magdalini; BEAU, Fabrice et al.Journal of medicinal chemistry (Print). 2008, Vol 51, Num 7, pp 2216-2226, issn 0022-2623, 11 p.Article

Phosphinic Tripeptides as Dual Angiotensin-Converting Enzyme C-Domain and Endothelin-Converting Enzyme-1 InhibitorsJULLIEN, Nicolas; MAKRITIS, Anastasios; GEORGIADIS, Dimitris et al.Journal of medicinal chemistry (Print). 2010, Vol 53, Num 1, pp 208-220, issn 0022-2623, 13 p.Article

Design, Synthesis, and Evaluation of Novel Organophosphorus Inhibitors of Bacterial UreasesVASSILIOU, Stamatia; GRABOWIECKA, Agnieszka; KOSIKOWSKA, Paulina et al.Journal of medicinal chemistry (Print). 2008, Vol 51, Num 18, pp 5736-5744, issn 0022-2623, 9 p.Article

Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: Insights from selective inhibitorsGEORGIADIS, Dimitris; BEAU, Fabrice; CZARNY, Bertrand et al.Circulation research. 2003, Vol 93, Num 2, pp 148-154, issn 0009-7330, 7 p.Article

Inhibition of Zinc Metallopeptidases in Cardiovascular Disease - From Unity to Trinity, or Duality?DIVE, Vincent; CHANG, Cheng-Fu; YIOTAKIS, Athanasios et al.Current pharmaceutical design (Print). 2009, Vol 15, Num 31, pp 3606-3621, issn 1381-6128, 16 p.Article

Anterior pituitary pyroglutamyl peptidase II activity controls TRH-induced prolactin releaseCRUZ, Raymundo; VARGAS, Miguel Angel; URIBE, Rosa Maria et al.Peptides (New York, NY. 1980). 2008, Vol 29, Num 11, pp 1953-1964, issn 0196-9781, 12 p.Article

Dosing and scheduling influence the antitumor efficacy of a phosphinic peptide inhibitor of matrix metalloproteinasesDIVE, Vincent; ANDARAWEWA, Kumari L; BOULAY, Anne et al.International journal of cancer. 2005, Vol 113, Num 5, pp 775-781, issn 0020-7136, 7 p.Article

A Selective Matrix Metalloproteinase-12 Inhibitor Retards Atherosclerotic Plaque Development in Apolipoprotein E-Knockout MiceJOHNSON, Jason L; DEVEL, Laurent; CZARNY, Bertrand et al.Arteriosclerosis, thrombosis, and vascular biology. 2011, Vol 31, Num 3, pp 528-535, issn 1079-5642, 8 p.Article

Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstrictionVAN ESCH, Joep H. M; TOM, Beril; DIVE, Vincent et al.Hypertension (Dallas, Tex. 1979). 2005, Vol 45, Num 1, pp 120-125, issn 0194-911X, 6 p.Article

Matrix Metalloproteinase Inhibition Protects Rat Livers from Prolonged Cold Ischemia-Warm Reperfusion InjuryDEFAMIE, Virginie; LAURENS, Marina; DIVE, Vincent et al.Hepatology (Baltimore, Md.). 2008, Vol 47, Num 1, pp 177-185, issn 0270-9139, 9 p.Article

  • Page / 1